Q2 2022 Immunoprecise Antibodies Ltd Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ImmunoPrecise Antibodies fiscal year 2022 second-quarter earnings results and business highlights call. (Operator Instructions). Following the presentation, we will answer pre-submitted questions. (Operator Instructions). I would like to remind everyone that this conference call is being recorded today, December 13th, at 4:30 Eastern Time. I will now turn the call over to Chris Chu. Mr. Chu, please go ahead.
Thank you, and welcome. Dr. Jennifer Bath, President and Chief Executive Officer of ImmunoPrecise; and Ms. Lisa Helbling, Chief Financial Officer, will be the speakers on today's call. A Q&A period answering pre-submitted questions will follow their summary of the quarter followed by closing remarks. Before Dr. Bath begins, I've been asked by ImmunoPrecise to read the following Safe Harbor regarding forward-looking statements.
I would like to remind everyone that ImmunoPrecise's remarks today contain forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |